Literature DB >> 23201306

Cognition and the five-factor model of the positive and negative syndrome scale in schizophrenia.

Roberto Rodriguez-Jimenez1, Alexandra Bagney, Laura Mezquita, Isabel Martinez-Gras, Eva-Maria Sanchez-Morla, Natalia Mesa, Manuel-Ignacio Ibañez, Justo Diez-Martin, Miguel-Angel Jimenez-Arriero, Antonio Lobo, Jose-Luis Santos, Tomas Palomo.   

Abstract

Different exploratory and confirmatory factorial analyses of the Positive and Negative Syndrome Scale (PANSS) have found a number of factors other than the original positive, negative, and general psychopathology. Based on a review of previous studies and using confirmatory factor analyses (CFA), Wallwork et al. (Schizophr Res 2012; 137: 246-250) have recently proposed a consensus five-factor structure of the PANSS. This solution includes a cognitive factor which could be a useful measure of cognition in schizophrenia. Our objectives were 1) to study the psychometric properties (factorial structure and reliability) of this consensus five-factor model of the PANSS, and 2) to study the relationship between executive performance assessed using the Wisconsin Card Sorting Test (WCST) and the proposed PANSS consensus cognitive factor (composed by items P2-N5-G11). This cross-sectional study included a final sample of 201 Spanish outpatients diagnosed with schizophrenia. For our first objective, CFA was performed and Cronbach's alphas of the five factors were calculated; for the second objective, sequential linear regression analyses were used. The results of the CFA showed acceptable fit indices (NNFI=0.94, CFI=0.95, RMSEA=0.08). Cronbach's alphas of the five factors were adequate. Regression analyses showed that this five-factor model of the PANSS explained more of the WCST variance than the classical three-factor model. Moreover, higher cognitive factor scores were associated with worse WCST performance. These results supporting its factorial structure and reliability provide robustness to this consensus PANSS five-factor model, and indicate some usefulness of the cognitive factor in the clinical assessment of schizophrenic patients.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23201306     DOI: 10.1016/j.schres.2012.10.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  16 in total

1.  Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.

Authors:  Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

2.  The Prevalence of Suicide Attempts and Independent Demographic and Clinical Correlates among Chronic Schizophrenia Patients in Agricultural Areas of China.

Authors:  Yi Zhong; Lei Xia; Tong-Tong Zhao; Yu-Long Zhang; Ye-Lei Zhang; Wen-Zheng Li; Yan-Qiong Hu; Xian-Hu Yao; Gabor S Ungvari; Lloyd Balbuena; Huan-Zhong Liu; Yu-Tao Xiang
Journal:  Psychiatr Q       Date:  2019-12

3.  The intrasubjectivity of self, voices and delusions: A phenomenological analysis.

Authors:  Cherise Rosen; Nev Jones; Kayla A Chase; Hannah Gin; Linda S Grossman; Rajiv P Sharma
Journal:  Psychosis       Date:  2016-04-11

4.  Effects of sample size and distributional assumptions on competing models of the factor structure of the PANSS and BPRS.

Authors:  Stephen J Tueller; Kiersten L Johnson; Kevin J Grimm; Sarah L Desmarais; Brian G Sellers; Richard A Van Dorn
Journal:  Int J Methods Psychiatr Res       Date:  2016-12-02       Impact factor: 4.035

5.  Sex differences in prevalence and clinical correlates of insomnia in Chinese patients with chronic schizophrenia.

Authors:  Rongrong Zhu; Dongmei Wang; Huixia Zhou; Wenjia Wang; Shuochi Wei; Dachun Chen; Meihong Xiu; Li Wang; Xiang-Yang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-08-16       Impact factor: 5.760

6.  Demographics, clinical characteristics and cognitive symptoms of heavy smokers and non-heavy smokers in Chinese male patients with chronic schizophrenia.

Authors:  Shuochi Wei; Dongmei Wang; Huixia Zhou; Luyao Xia; Yang Tian; Qilong Dai; Rongrong Zhu; Wenjia Wang; Dachun Chen; Meihong Xiu; Li Wang; Xiangyang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-26       Impact factor: 5.760

7.  Neurobiological Divergence of the Positive and Negative Schizophrenia Subtypes Identified on a New Factor Structure of Psychopathology Using Non-negative Factorization: An International Machine Learning Study.

Authors:  Ji Chen; Kaustubh R Patil; Susanne Weis; Kang Sim; Thomas Nickl-Jockschat; Juan Zhou; André Aleman; Iris E Sommer; Edith J Liemburg; Felix Hoffstaedter; Ute Habel; Birgit Derntl; Xiaojin Liu; Jona M Fischer; Lydia Kogler; Christina Regenbogen; Vaibhav A Diwadkar; Jeffrey A Stanley; Valentin Riedl; Renaud Jardri; Oliver Gruber; Aristeidis Sotiras; Christos Davatzikos; Simon B Eickhoff
Journal:  Biol Psychiatry       Date:  2019-09-23       Impact factor: 12.810

8.  Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia.

Authors:  Manli Huang; Yi Huang; Liang Yu; Jianbo Hu; Jinkai Chen; Pingbo Jin; Weijuan Xu; Ning Wei; Shaohua Hu; Hongli Qi; Yi Xu
Journal:  BMC Psychiatry       Date:  2016-10-06       Impact factor: 3.630

9.  Cognitive functioning among patients with schizophrenia in a Nigerian hospital: a comparison with mood disorder.

Authors:  Adeniran Olubunmi Okewole; Abiodun Olugbenga Adewuya; Roger Olatokunbo Aderibigbe Makanjuola
Journal:  Schizophr Res Cogn       Date:  2014-10-12

10.  Facial emotion recognition impairment is related to disorganisation in multi-episode schizophrenia.

Authors:  Anna Comparelli; Antonella De Carolis; Valentina Corigliano; Giada Trovini; Julia Dehning; Simone Di Pietro; Eleonora De Pisa; Silvana Galderisi; Paolo Girardi
Journal:  Schizophr Res Cogn       Date:  2014-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.